Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

Electronic Approach to the Human Massage Therapist

Study ID: NCT07040397
Start Date: 2026-02-28
End Date: 2026-10-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

EMMA massage therapy

Clinical massage treatment

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Gender Affirming Hormone Therapy and Immune Function in Trans Individuals - The GIFT Study

Study ID: NCT07358897
Start Date: 2026-02-16
End Date: 2029-01-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment
Sponsor

Imperial College London

Source: clinicaltrials.gov

Share:
Add to list

Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome

Study ID: NCT04381897
Start Date: 2026-03-01
End Date: 2027-05-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

10

Intervention / Treatment

N-acetyl cysteine

Placebo

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

Adaptive Text Messaging and Non-Monetary Incentives to Sustain ART Adherence Among Adolescents Living With HIV in Ethiopia

Study ID: NCT07377760
Start Date: 2026-03-09
End Date: 2027-03-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

327

Intervention / Treatment

Non-adaptive reminder text messaging

Adaptive interventions

The control arm

Sponsor

Arba Minch University

Source: clinicaltrials.gov

Share:
Add to list

Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery

Study ID: NCT05936580
Start Date: 2026-04
End Date: 2027-02
Study Type

Interventional

Study Phase

Phase4

No. of Participants

28

Intervention / Treatment

Nouq

Sponsor

Octapharma

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

Study ID: NCT07293351
Start Date: 2026-03-26
End Date: 2031-11-26
Study Type

Interventional

Study Phase

Phase2

No. of Participants

264

Intervention / Treatment

Cool down

Ipilimumab

Cabozantinib

Nivolumab

Sponsor

Bristol-Myers Squibb

Source: clinicaltrials.gov

Share:
Add to list

Design and Feasibility of an SMS-based Safety Planning Intervention

Study ID: NCT07365579
Start Date: 2026-04
End Date: 2027-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Text Messaging based Safety Planning Intervention

Facilitated Referral to Crisis Resources

Sponsor

Northwestern University

Source: clinicaltrials.gov

Share:
Add to list

Application of Digital Twins' Technology in Patients Who Had a Stroke, with Moyamoya Disease and with Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: a Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)

Study ID: NCT06714097
Start Date: 2026-04
End Date: 2027-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

AI

healthy dialogue

Sponsor

I.R.C.C.S. Foundation Carlo Besta Neurological Institute

Source: clinicaltrials.gov

Share:
Add to list

Short-Term Glycemic Effects of Liquid Metformin vs Standard Tablets

Study ID: NCT07300059
Start Date: 2026-07-15
End Date: 2026-08-28
Study Type

Interventional

Study Phase

Phase1

No. of Participants

24

Intervention / Treatment

Liquid Metformin 100 mg/mL

Liquid Metformin 250 mg/mL

Standard Metformin Immediate-Release Tablet

Sponsor

Asparagus Labs, Inc

Source: clinicaltrials.gov

Share:
Add to list

Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Study ID: NCT07040982
Start Date: 2026-05-01
End Date: 2028-06-13
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Asciminib

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Echocardiography Test

Survey Administration

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list